Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis

Internal Medicine Journal

Volumn 34, Issue 9-10, 2004, Pages 570-572

  Smith, G R ^a   Tymms, K E ^a   Falk, M ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

AA amyloidosis; Nephrotic syndrome; Rheumatoid arthritis; Treatment; Tumour necrosis factor

Indexed keywords

AMYLOID; ANTIRHEUMATIC AGENT; ATORVASTATIN; AZATHIOPRINE; C REACTIVE PROTEIN; CALCITRIOL; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; METHOTREXATE; OMEPRAZOLE; PREDNISOLONE; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; BLEEDING; BONE MARROW TOXICITY; CASE REPORT; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEHYDRATION; DEVELOPED COUNTRY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HUMERUS FRACTURE; INFERTILITY; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; LEUKEMIA; MORTALITY; NEPHROSIS; NEPHROTIC SYNDROME; OVARY CYST; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RHEUMATOID ARTHRITIS; ULCER PERFORATION; URINARY EXCRETION; VEIN THROMBOSIS; WEIGHT REDUCTION;

AMYLOIDOSIS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; KIDNEY DISEASES; MIDDLE AGED; NEPHROTIC SYNDROME; RECEPTORS, TUMOR NECROSIS FACTOR; SERUM AMYLOID A PROTEIN;

EID: 8344222831     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00605.x     Document Type: Article

References (16)

1. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991; 70: 246-56.
2. Husby G. Treatment of amyloidosis and the rheumatologist: state of the art and perspectives for the future. Scand J Rheumatol 1998; 27: 161-5.
3. Gottenberg J, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautril B et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis Rheum 2003; 48: 2019-24.
4. Gillmore J, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid protein. Lancet 2001; 358: 24-9.
5. Komatsuda A, Monta K, Ohtani H, Yamaguchi A, Miura AB. Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis 1998; 32: E7.
6. Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine: a case report. Arthritis Rheum 1995; 38: 1851-4.
7. Matsuda M, Morita H, Ikeda S. Long-term follow up of systemic reactive AA amyloidosis secondary to rheumatoid arthritis: successful treatment with intermediate-dose corticosteroid. Intern Med 2000; 41: 335-6.
8. Cunnane G, Whitehead AS. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology 2001; 40: 821-5.
9. Weinblatt ME, Kremer JM, Bankhurst AD et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-9.
10. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC. Etanercept in children with polyarticular juvenile arthritis. N Engl J Med 2000; 342: 763-9.
11. German JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumour necrosis factor-α. N Engl J Med 2002; 346: 1349-56.
12. Pai R, Bassa B, Kirschenbaum MA, Kamanna VS. TNF stimulates monocyte adhesion to glomerular mesangial cells: the role of intercellular adhesion molecule-1 gene expression and protein kinases. J Immunol 1996; 156: 2571-9.
13. Cunnane G, Whitehead AS. Amyloid precursors and amyloidosis in rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 615-28.
14. Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum 2002; 46: 2571-3.
15. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor associated periodic syndrome. N Engl J Med 1999; 340: 253-9.
16. 123I-labeled serum amyloid P component. N Engl J Med 1990; 323: 508-13.